ATE243683T1 - Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln - Google Patents

Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln

Info

Publication number
ATE243683T1
ATE243683T1 AT98939677T AT98939677T ATE243683T1 AT E243683 T1 ATE243683 T1 AT E243683T1 AT 98939677 T AT98939677 T AT 98939677T AT 98939677 T AT98939677 T AT 98939677T AT E243683 T1 ATE243683 T1 AT E243683T1
Authority
AT
Austria
Prior art keywords
polyhydroxybutylpyrazine
production
products containing
medicinal products
polyhydroxybutylpyrazines
Prior art date
Application number
AT98939677T
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE243683T1 publication Critical patent/ATE243683T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98939677T 1997-07-17 1998-07-15 Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln ATE243683T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
PCT/FR1998/001543 WO1999003841A1 (fr) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
ATE243683T1 true ATE243683T1 (de) 2003-07-15

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98939677T ATE243683T1 (de) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln

Country Status (25)

Country Link
US (1) US6288066B1 (de)
EP (1) EP1001942B1 (de)
JP (1) JP4443033B2 (de)
KR (1) KR20010021871A (de)
CN (1) CN1264368A (de)
AT (1) ATE243683T1 (de)
AU (1) AU745905B2 (de)
BR (1) BR9810595A (de)
CA (1) CA2296725C (de)
CZ (1) CZ290896B6 (de)
DE (1) DE69815854T2 (de)
DK (1) DK1001942T3 (de)
ES (1) ES2196595T3 (de)
FR (1) FR2766183B1 (de)
HU (1) HUP0004661A3 (de)
IL (1) IL134039A0 (de)
MX (1) MXPA00000437A (de)
NO (1) NO20000199L (de)
NZ (1) NZ502279A (de)
PL (1) PL338147A1 (de)
PT (1) PT1001942E (de)
RU (1) RU2186773C2 (de)
SK (1) SK462000A3 (de)
WO (1) WO1999003841A1 (de)
ZA (1) ZA986336B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
EP2121611B1 (de) * 2007-03-19 2015-04-15 DSM IP Assets B.V. Auf alpha,beta-Dihydroxyketonen basierende UV-Filter-Verbindungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600052A1 (de) * 1986-01-03 1987-07-09 Merck Patent Gmbh Heterocyclische verbindungen
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
IL134039A0 (en) 2001-04-30
CA2296725A1 (fr) 1999-01-28
CZ2000121A3 (cs) 2000-05-17
NO20000199D0 (no) 2000-01-14
CZ290896B6 (cs) 2002-11-13
AU8810398A (en) 1999-02-10
AU745905B2 (en) 2002-04-11
HUP0004661A2 (hu) 2001-11-28
EP1001942A1 (de) 2000-05-24
EP1001942B1 (de) 2003-06-25
CN1264368A (zh) 2000-08-23
RU2186773C2 (ru) 2002-08-10
NZ502279A (en) 2002-04-26
DE69815854D1 (de) 2003-07-31
JP2001510185A (ja) 2001-07-31
ZA986336B (en) 1999-01-27
DE69815854T2 (de) 2004-05-13
CA2296725C (fr) 2008-11-18
JP4443033B2 (ja) 2010-03-31
SK462000A3 (en) 2000-06-12
BR9810595A (pt) 2000-09-12
MXPA00000437A (es) 2002-04-17
HUP0004661A3 (en) 2001-12-28
FR2766183A1 (fr) 1999-01-22
PT1001942E (pt) 2003-11-28
ES2196595T3 (es) 2003-12-16
US6288066B1 (en) 2001-09-11
PL338147A1 (en) 2000-09-25
FR2766183B1 (fr) 1999-08-27
NO20000199L (no) 2000-01-14
WO1999003841A1 (fr) 1999-01-28
KR20010021871A (ko) 2001-03-15
DK1001942T3 (da) 2003-10-20

Similar Documents

Publication Publication Date Title
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
DE69604653D1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
NO941678D0 (no) nor-gallesyrederivater, fremgangsmåte for fremstilling og anvendelse av dem som legemiddel
NO174877C (no) Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
DE69715888D1 (de) Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel
ATE124951T1 (de) Fluorcytidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
ATE194920T1 (de) Pro-prodrugs, ihre herstellung und anwendung
ATE62683T1 (de) Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
ES2088959T3 (es) 11-beta-aril-4-estreno, procedimiento para su preparacion y aplicacion como medicamento.
BR0311347A (pt) Alcanóis bis-aromáticos
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
DE69815854D1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
DK197689A (da) Pyridazinderivater
NO932502L (no) Nye fosfolipidderivater
DE3880348D1 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ES2179029T3 (es) Derivados de 14,15-alfa-metileno-equilenina, proceso para su preparacion y medicamentos que contienen los mismos.
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1001942

Country of ref document: EP

REN Ceased due to non-payment of the annual fee